Skip to main content
logo
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.12
+0.14 (2.01%)
At close: Mar 9, 2026, 4:00 PM EDT
7.03
-0.09 (-1.33%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Aligos Therapeutics Revenue

In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%. Aligos Therapeutics had revenue of $169.00K in the quarter ending December 31, 2025, a decrease of -73.13%.

Revenue (ttm)
$2.19M
Revenue Growth
-44.59%
P/S Ratio
19.89
Revenue / Employee
$31,229
Employees
70
Market Cap
44.06M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.19M-1.76M-44.59%
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xilio Therapeutics31.80M
Veru Inc.16.89M
Palatin Technologies8.96M
Apollomics6.93M
Lipocine4.32M
Revenue Rankings

ALGS News

More News